April 2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GPCR-Targeted Drug Discovery " Apr.19.2022 　 Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara ; “Ono”) today announced that it has newly signed a collaboration